These findings suggest that the inhibition of ATF6, besides potentiating the cytotoxic effect of ER stressors against colon cancer cells, could be exploited to potentiate the anti-cancer effect of DNA damaging agents, due to the impairment of DDR. The gene discussed is ATF6; the disease is malignant colon neoplasm.